Bio Path Holdings Stock Market Value
| BPTH Stock | USD 0.07 0.01 15.83% |
| Symbol | Bio |
Bio Path 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Path's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Path.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Bio Path on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Path Holdings or generate 0.0% return on investment in Bio Path over 90 days. Bio Path is related to or competes with Orgenesis, and Helix BioMedix. Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug developmen... More
Bio Path Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Path's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Path Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.94 | |||
| Information Ratio | 0.0082 | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 16.67 |
Bio Path Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Path's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Path's standard deviation. In reality, there are many statistical measures that can use Bio Path historical prices to predict the future Bio Path's volatility.| Risk Adjusted Performance | 0.0212 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.64) | |||
| Sortino Ratio | 0.0054 | |||
| Treynor Ratio | 0.0416 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0212 | |||
| Market Risk Adjusted Performance | 0.0516 | |||
| Mean Deviation | 6.6 | |||
| Semi Deviation | 7.96 | |||
| Downside Deviation | 15.94 | |||
| Coefficient Of Variation | 6753.96 | |||
| Standard Deviation | 10.56 | |||
| Variance | 111.47 | |||
| Information Ratio | 0.0082 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.64) | |||
| Sortino Ratio | 0.0054 | |||
| Treynor Ratio | 0.0416 | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 16.67 | |||
| Downside Variance | 254.13 | |||
| Semi Variance | 63.37 | |||
| Expected Short fall | (16.92) | |||
| Skewness | 0.2321 | |||
| Kurtosis | 0.2674 |
Bio Path Holdings Backtested Returns
Bio Path is out of control at the moment. Bio Path Holdings secures Sharpe Ratio (or Efficiency) of 0.014, which signifies that the company had a 0.014 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Bio Path Holdings, which you can use to evaluate the volatility of the firm. Please confirm Bio Path's Downside Deviation of 15.94, risk adjusted performance of 0.0212, and Mean Deviation of 6.6 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%. Bio Path has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 3.52, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio Path will likely underperform. Bio Path Holdings right now shows a risk of 10.82%. Please confirm Bio Path Holdings treynor ratio and the relationship between the semi variance and period momentum indicator , to decide if Bio Path Holdings will be following its price patterns.
Auto-correlation | 0.13 |
Insignificant predictability
Bio Path Holdings has insignificant predictability. Overlapping area represents the amount of predictability between Bio Path time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Path Holdings price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Bio Path price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Bio OTC Stock
Bio Path financial ratios help investors to determine whether Bio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Path security.